World-first Innovation in Cryosurgery
With 500,000 cases of breast tumours every year, Sanarus Medical’s minimally invasive Visica™ Treatment had a great future. But how could they turn that opportunity into a multi million dollar business when success relies upon a low-cost outpatient procedure with a simple, effective device? They called upon CDP’s inventive engineering-physics, and walked away with a market-leading technology just 8 months later.
Sanarus and CDP collaborated to invent the world’s first low-pressure liquid nitrogen cryosurgery system. The result was that low-cost materials and joining methods could be used on the disposable part, and the size of the nitrogen store could be massively reduced. Visica™ is now used to kill breast-tumours without the need for open surgery.
Skills Deployed
• Thermodynamics physics
• Methodical laboratory experimentation
• Construction of electromechanical demo systems
Technical Highlights and ‘World Firsts’
• World’s first low-pressure nitrogen cryoablation system
• Reduction of the mass of the system by a factor of 10
• Procedure time reduced by 50%
Sanarus has much more than a revolutionary new product on the market; their business value is secured by a powerful patent portfolio enhanced by CDP’s work.
